120 related articles for article (PubMed ID: 24533477)
21. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
22. Circulating angiogenic factors and preeclampsia.
Tsatsaris V; Goffin F; Foidart JM
N Engl J Med; 2004 May; 350(19):2003-4; author reply 2003-4. PubMed ID: 15128904
[No Abstract] [Full Text] [Related]
23. Angiogenic balance in pregnancy and subsequent breast cancer risk and survival: a population study.
Vatten LJ; Romundstad PR; Jenum PA; Eskild A
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2074-8. PubMed ID: 19567504
[TBL] [Abstract][Full Text] [Related]
24. Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.
Staff AC; Harsem NK; Braekke K; Hyer M; Hoover RN; Troisi R
Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):29-33. PubMed ID: 19135290
[TBL] [Abstract][Full Text] [Related]
25. Emerging new biomarkers of preeclampsia.
Polsani S; Phipps E; Jim B
Adv Chronic Kidney Dis; 2013 May; 20(3):271-9. PubMed ID: 23928393
[TBL] [Abstract][Full Text] [Related]
26. Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia.
Dwyer BK; Krieg S; Balise R; Carroll IR; Chueh J; Nayak N; Druzin M
J Matern Fetal Neonatal Med; 2010 Jul; 23(7):705-11. PubMed ID: 19895348
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
28. Biomarker for hypertension-preeclampsia: are we close yet?
Sibai BM
Am J Obstet Gynecol; 2007 Jul; 197(1):1-2. PubMed ID: 17618741
[No Abstract] [Full Text] [Related]
29. The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis.
de Jesus GR; de Jesus NR; Levy RA; Klumb EM
Lupus; 2014 Oct; 23(12):1299-301. PubMed ID: 25228732
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers in pre-eclampsia: a novel approach to early detection of the disease.
Masoura S; Kalogiannidis IA; Gitas G; Goutsioulis A; Koiou E; Athanasiadis A; Vavatsi N
J Obstet Gynaecol; 2012 Oct; 32(7):609-16. PubMed ID: 22943702
[TBL] [Abstract][Full Text] [Related]
31. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
[TBL] [Abstract][Full Text] [Related]
32. Levels of antiangiogenic factors in preeclamptic pregnancies.
Zhao W; Qiao J; Zhang Q; Zhao Y; Chen Q
Growth Factors; 2010 Aug; 28(4):293-8. PubMed ID: 20214506
[TBL] [Abstract][Full Text] [Related]
33. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
34. Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia.
López-Novoa JM
Nephrol Dial Transplant; 2007 Mar; 22(3):712-4. PubMed ID: 17210583
[No Abstract] [Full Text] [Related]
35. PROGNOSIS looking good for a possible serum test for preeclampsia.
Dowdall M
Future Cardiol; 2014 Mar; 10(2):164-5. PubMed ID: 24883442
[No Abstract] [Full Text] [Related]
36. Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption.
Tikkanen M; Stenman UH; Nuutila M; Paavonen J; Hiilesmaa V; Ylikorkala O
Prenat Diagn; 2007 Dec; 27(12):1143-6. PubMed ID: 17960788
[TBL] [Abstract][Full Text] [Related]
37. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin-to-twin transfusion syndrome.
Prefumo F; Pagani G; Fratelli N; Benigni A; Frusca T
Prenat Diagn; 2010 Apr; 30(4):378-9. PubMed ID: 20127899
[No Abstract] [Full Text] [Related]
38. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
[TBL] [Abstract][Full Text] [Related]
39. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
40. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
